Strides Pharma Science Ltd.

27 Oct, 2020, 03:58 PM IST
27 Oct, 2020, 04:00 PM IST
NSE
BSE
735.65-12.90-1.72%
Today's Trend
Low
732.40
High
751.15
Volume
457,283
Open
748.45
Prev Close
748.55
735.40-12.75-1.70%
Today's Trend
Low
732.05
High
750.70
Volume
11,573
Open
732.05
Prev Close
748.15
Open trading A/c + Watchlist
+ Portfolio

Technical Chart

  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
Bid
Offer

Mkt Cap (₹ Cr.)

6593.31
6623.34

Face Value (₹)

10.00
10.00
P/E (x)
48.39
48.61
EPS-TTM(₹)
15.20
15.20
P/B (x)
1.14
1.14
BV/Sh(x)
289.50
289.50
Div. Yield(%)
1.90
1.89
52Wk L/H
268.00
764.40
271.00
764.60

Strides Pharma Science Ltd.
News & Recos

  • Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
  • Certificate Pursuant To Regulation 40 (9) Of SEBI (LODR) Regulations, 2015.
  • Compliance Certificate - For The Half - Year Ended 30.09.2020
  • Announcement under Regulation 30 (LODR)-Newspaper Publication
  • Board Meeting Intimation for Announcement Of Board Meeting Under Regulation 29 (1) Of SEBI Listing Regulations
  • Disclosures under Reg. 10(5) in respect of acquisition under Reg. 10(1)(a) of SEBI (SAST) Regulations, 2011
  • Disclosures under Reg. 10(5) in respect of acquisition under Reg. 10(1)(a) of SEBI (SAST) Regulations, 2011
  • Statement Of Investor Complaints For The Quarter Ended September 2020
  • Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
  • Shareholding for the Period Ended September 30, 2020
MORE FROM NEWS & RECOS

Strides Pharma Science Ltd. Share Price Updates

Strides Pharma Science Ltd. share price
down -1.72%
down -1.22%
from its previous close of Rs
748.55
748.15
. Strides Pharma Science Ltd. stock last traded price is
735.65
739.00
Strides Pharma Science Ltd. Share Price
Value
Today/Current/Last
735.65
739.00
Previous Day
748.55
748.15

Strides Pharma Science Ltd. Earnings
(Figures in Rs. Cr.)

Sales

Other Income

Operating Profit

Other Operating
Income

EBITDA

Interest

Depreciation

Tax

Net Profit

EPS (₹)

Jun 2020
% Chg (Quarterly)
% Chg (Yearly)
Peer Range
Trend
781.80
26.37
14.00
0.00
7585.25
0.00
0.00
0.00
-0.72
118.06
154.90
138.17
28.10
-14.20
2526.83
12.30
-30.28
20.05
0.00
153.79
167.21
102.21
27.48
-14.20
2526.83
36.91
-8.48
4.44
0.00
102.00
49.13
8.36
14.55
0.00
495.92
3.28
NA
5.22
-110.66
305.90
103.56
NA
2699.03
-1655.60
780.58
11.56
NA
2719.51
-10.81
68.30

Strides Pharma Science Ltd. Stock Performance

Period:
LTP
%Change
Trend
735.65
-1.72
293.85
0.72
168.05
-0.36
456.20
-0.15
157.00
-0.44
335.70
1.22
148.30
-0.67
349.85
1.42
517.95
-1.18
677.20
-4.99
656.15
-1.52

Strides Pharma Science Ltd. Financial Performance

LTP
(₹)
Market Cap
(Cr.)
Price to
Book
Price to
Earnings
PAT
Margins
RoE%
RoA%
Debt to
Equity
Avg. Cost
of Funds%
Current
Ratio
735.65
6589.28
1.14
48.36
5.0000
10.9500
0.5900
0.73
6.1900
0.93
168.05
4412.88
-135.69
-27.32
-406.6900
-832.4200
-114.6100
-3.64
0.0000
0.29
517.95
3922.45
2.45
17.89
24.9100
27.4800
19.0900
0.04
0.0000
5.70
335.70
4283.69
3.04
14.35
32.2300
39.0100
27.0200
0.22
9.0800
1.95
349.85
5973.80
2.17
21.69
17.9200
20.7000
13.2300
0.00
0.9100
3.76
293.85
3254.59
0.72
4.42
-1.5200
-1.4100
-0.8400
0.80
0.0000
0.69
456.20
3713.14
1.50
16.38
17.0600
12.2200
7.8600
0.25
1.5500
1.52
677.20
6311.50
1.81
25.52
7.8200
22.5400
8.9600
0.52
1.2900
1.45
656.15
3854.02
1.23
9.55
19.0700
62.0300
30.7300
0.07
2.5200
2.38
148.30
3682.10
2.60
46.39
6.9500
12.3700
4.6000
0.38
0.0000
1.50
157.00
2453.66
0.15
19.70
8.8200
4.2600
2.1900
0.16
0.0500
1.15

Strides Pharma Science Ltd. Financial Comparison with peers

Management Efficiency

Return On Equity (%)

Return On Assets (%)

Return On Capital Employed (%)

Fixed Assets Turnover (x)

Profitability & Growth

Gross Profit Margin (%)

Operating Profit Margin (%)

Net Profit Margin (%)

Financial Strength
Liquidity

Quick Ratio (x)

Current Ratio (x)

Cash Ratio (x)

Solvency

Debt Equity Ratio (x)

Coverage Ratios

Cash Flows to Long Term Debt (x)

Strides Pharma Science Ltd.
Peer
Average
Peer Range
Trend
1.44
6.15
-97.73
37.52
0.65
4.29
-51.80
37.98
8.16
7.12
-86.49
32.77
0.53
0.43
-36.70
3.05
12.43
-3.48
-831.69
43.32
18.74
3.00
-802.77
46.18
1.32
-9.07
-653.62
38.01
1.22
2.00
0.08
37.52
1.79
2.77
0.21
37.52
0.14
0.24
0.00
2.43
0.24
0.24
0.00
3.08
4.56
2.78
0.00
24.88

Strides Pharma Science Ltd. Share Holding

  • Categories
    No. Of Shares
    %
  • NoOfShares
    89,625,664
    100.00
  • Promoters
    26,435,081
    29.49
  • ForeignInstitutions
    24,164,957
    26.96
  • NBanksMutualFunds
    13,548,244
    15.12
  • Others
    11,588,723
    12.93
  • GeneralPublic
    13,568,608
    15.14
  • FinancialInstitutions
    145,051
    0.16
  • ForeignPromoter
    175,000
    0.20

Mutual Fund Ownership

Category
Rating
No. of shares
%Change in Shares
(MOM basis)
% of AUM
Amount Invested
(in ₹ Cr)
Equity: Multi Cap
3003131
0.00%
1.99%
216.09
Equity: Large Cap
2069863
0.00%
0.68%
148.94
Equity: ELSS
1840000
0.00%
1.79%
132.40
Equity: Mid Cap
1338241
0.00%
2.63%
96.29
Equity: Mid Cap
1122216
0.00%
0.37%
80.75

Liquid, Ultra Short Term funds and FMPs are not taken into account.

More Schemes

About Strides Pharma Science Ltd.

Strides Pharma Science Ltd., incorporated in the year 1990, is a Mid Cap company (having a market cap of Rs 6593.31 Crore) operating in Pharmaceuticals sector.

Strides Pharma Science Ltd. key Products/Revenue Segments include Pharmaceuticals which contributed Rs 1524.27 Crore to Sales Value (91.04 % of Total Sales), Other Operating Revenue which contributed Rs 82.52 Crore to Sales Value (4.92 % of Total Sales), Export Incentives which contributed Rs 33.12 Crore to Sales Value (1.97 % of Total Sales), Royalty Income which contributed Rs 24.73 Crore to Sales Value (1.47 % of Total Sales) and Sale of services which contributed Rs 9.51 Crore to Sales Value (0.56 % of Total Sales)for the year ending 31-Mar-2020.

For the quarter ended 30-06-2020, the company has reported a Consolidated sales of Rs 781.80 Crore, up 26.37 % from last quarter Sales of Rs 618.64 Crore and up 14.00 % from last year same quarter Sales of Rs 685.80 Crore Company has reported net profit after tax of Rs 122.80 Crore in latest quarter.

The company’s top management includes Dr.Kausalya Santhanam, Dr.R Ananthanarayanan, Mr.Arun Kumar, Mr.Badree Komandur, Mr.Bharat D Shah, Mr.Deepak Vaidya, Mr.Homi Rustam Khusrokhan, Mr.S Sridhar, Ms.Sangita Reddy. Company has BSR & Co. LLP as its auditors. As on 30-09-2020, the company has a total of 89,625,664 shares outstanding.

Loading data...
Text Size:AAA
Markets Data
Markets Data
GetET MarketsAPP